BC

Byers Capital

North America, California, United States, San Francisco

Description

Byers Capital focuses on investing in startups in Series A + B rounds.

Investor Profile

Byers Capital has made 12 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Series B (17%)
  • Series D (8%)
  • Seed (8%)
  • Series E (8%)
  • Series C (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Health Diagnostics
  • Personal Health
  • Software
  • Wellness
  • Cloud Computing
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Byers Capital frequently co-invest with?

Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 3
Emerson Collective
North America, California, United States, Palo Alto
Co-Investments: 2
Parker Institute for Cancer Immunotherapy
North America, California, United States, San Francisco
Co-Investments: 3
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 2
Menlo Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Lux Capital
North America, New York, United States, New York
Co-Investments: 2
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does Byers Capital often collaborate with?

DA
North America, California, United States, San Francisco
Shared Deals: 1
PH
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
JS
North America, Massachusetts, United States, Boston
Shared Deals: 1
TN
North America, California, United States, San Francisco
Shared Deals: 1
CZ
North America, California, United States, San Francisco
Shared Deals: 1
GW
North America, California, United States, San Francisco
Shared Deals: 1
AK
North America, Massachusetts, United States, Boston
Shared Deals: 1
NK
North America, New York, United States, New York
Shared Deals: 1
JB
North America, California, United States, San Francisco
Shared Deals: 1
SL
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Byers Capital?

ArsenalBio

South San Francisco, California, United States

ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.

BiotechnologyCloud ComputingLife ScienceMedical
Series CSep 4, 2024
Amount Raised: $325,000,000
PinkDx

Indianapolis, Indiana, United States

PinkDx is a biotechnology company.

BiopharmaBiotechnology
Series AApr 25, 2024
Amount Raised: $40,000,000
Xaira Therapeutics

San Francisco, California, United States

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

Artificial Intelligence (AI)BiotechnologyHealth CareTherapeutics
Series AApr 23, 2024
Amount Raised: $1,000,000,000
Vial

San Francisco, California, United States

Scalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics.

BiotechnologyClinical TrialsHealth CareMedical
Series BNov 30, 2022
Amount Raised: $67,000,000
ArsenalBio

South San Francisco, California, United States

ArsenalBio is a programmable cell therapy company that offers advanced CAR T-cell therapies for solid tumors.

BiotechnologyCloud ComputingLife ScienceMedical
Series BSep 6, 2022
Amount Raised: $220,806,682
Waltz Health

Chicago, Illinois, United States

Waltz Health is a new digital health company.

FitnessHealth CareWellness
Series AApr 26, 2022
Amount Raised: $35,000,000
Getlabs

Miami, Florida, United States

Getlabs enables healthcare organizations to expand access and improve adherence by collecting diagnostics at home.

Health CareHealth DiagnosticsHome Health CareMedicalPersonal Health
Series AFeb 3, 2022
Amount Raised: $20,000,000
Synapticure

Chicago, Illinois, United States

We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US

Health CareMedicalNeuroscienceWellness
SeedFeb 2, 2022
Amount Raised: $6,000,000
Culdesac

Tempe, Arizona, United States

Culdesac reimagines cities for people, not cars.

Civil EngineeringConstructionReal Estate
Series AJan 20, 2022
Amount Raised: $30,000,000
Freenome

South San Francisco, California, United States

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

BiotechnologyHealth CareHealth DiagnosticsPersonal Health
Series DDec 7, 2021
Amount Raised: $300,000,000